SEATTLE, June 1 /PRNewswire-FirstCall/ -- Trubion
Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced it will
present a corporate update at the 9th Annual Needham Healthcare
Conference to be held at the New York Palace Hotel, 455 Madison
Avenue in New York City.
Michelle Burris, senior vice
president and chief operating officer, and John Bencich, vice president and chief financial
officer, are scheduled to present on Thursday, June 10 at 2:40
pm ET in the Henry conference room (5th floor). The
presentation will be available via audio webcast at:
http://www.wsw.com/webcast/needham38/trbn/.
(Logo:
http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO)
About Trubion
Trubion is a biopharmaceutical company that is creating a
pipeline of novel protein therapeutic product candidates to treat
autoimmune and inflammatory diseases and cancer. The Company's
mission is to develop a variety of first-in-class and best-in-class
product candidates, customized for optimal safety, efficacy and
convenience that it believes may offer improved patient
experiences. Trubion's current product candidates are novel
single-chain protein, or SMIP™, therapeutics, and are designed
using its custom drug assembly technology. Trubion's product
pipeline includes CD20-directed SMIP therapeutics such as TRU-015
and SBI-087 for autoimmune and inflammatory diseases, developed
under the Company's Pfizer collaboration. Trubion's product
pipeline also includes TRU-016, a novel CD37-targeted therapy for
the treatment of B-cell malignancies developed under the Company's
Facet collaboration. In addition to Trubion's current clinical
stage product pipeline, the Company is also developing its
multi-specific SCORPION™ technology, both for targeting
cell-surface molecules as well as simultaneously neutralizing
soluble ligands. More information is available in the investors
section of Trubion's website:
http://investors.trubion.com/index.cfm.
TRBN-G
Contact:
|
|
Jim DeNike
|
|
Senior Director,
Corporate and Marketing Communications
|
|
Trubion
Pharmaceuticals, Inc.
|
|
(206)
838-0500
|
|
jdenike@trubion.com
|
|
http://www.trubion.com
|
|
|
|
Amy Petty
|
|
Account Manager, Healthcare Practice
|
|
Waggener Edstrom Worldwide
|
|
(617) 576-5788
|
|
amyp@waggeneredstrom.com
|
|
|
SOURCE Trubion Pharmaceuticals, Inc.